Full Text View
Tabular View
No Study Results Posted
Related Studies
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) (NATHAN1)
This study has been completed.
Study NCT00977483   Information provided by MEDA Pharma GmbH & Co. KG

First Received on September 14, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Polyneuropathy
Additional conditions recognized in this trial
Diabetic Neuropathies
Polyneuropathies
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Interventions listed in this trial
Thioctic Acid (alpha-lipocic acid)
Placebo
Additional drug interventions recognized in this trial
Thioctic Acid
More general drug interventions related to this trial
Antioxidants
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Vitamin B Complex
Vitamins
Sponsors listed in this trial
MEDA Pharma GmbH & Co. KG
Clinquest, Inc.
Ergomed
Quintiles


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services